Heart Disease Trial, Recruiting NCT06967441 Sponsor: Minjae Yoon Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06967441
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 19 years or older who have been admitted to a cardiology ward with acute heart failure
  • People whose blood test shows a protein called NT-proBNP above 300 pg/mL, which is a marker of heart stress
  • People where the treating doctor suspects a possible respiratory viral infection, based on signs such as a fever above 38°C, a cough, other breathing-related symptoms, mucus, chest x-ray findings, or an elevated inflammation marker in the blood (CRP above 5 mg/dL)
  • People who have had a nose or throat swab tested for respiratory viruses within 72 hours of being admitted to hospital, for any of the three reasons above

Who may not be able to join:

  • People whose acute heart failure has a clear other identifiable cause, such as a heart attack, a dangerously slow heart rate needing a pacemaker, uncontrolled fast heart rate, severely uncontrolled high blood pressure, very low haemoglobin (a measure of red blood cells) below 7 g/dL, or heart failure triggered by not taking prescribed medications
  • People whose fluid on the lungs is mainly caused by a worsening of chronic kidney disease
  • People who have another clear source of infection that better explains their fever

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82-10-6334-1917

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Minjae Yoon
Registry
ClinicalTrials.gov
Start date
7 April 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Respiratory virus PCR detection rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov